MeadowBrook Investment Advisors LLC Sells 565 Shares of HealthEquity, Inc. (NASDAQ:HQY)

MeadowBrook Investment Advisors LLC reduced its stake in HealthEquity, Inc. (NASDAQ:HQY) by 13.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 3,510 shares of the company’s stock after selling 565 shares during the quarter. MeadowBrook Investment Advisors LLC’s holdings in HealthEquity were worth $337,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Paladin Wealth LLC acquired a new position in shares of HealthEquity in the third quarter valued at $39,000. UMB Bank n.a. grew its position in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after acquiring an additional 164 shares during the period. GAMMA Investing LLC grew its position in HealthEquity by 57.8% in the third quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock valued at $77,000 after acquiring an additional 344 shares during the period. Quarry LP grew its position in HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after acquiring an additional 1,089 shares during the period. Finally, 1620 Investment Advisors Inc. bought a new stake in HealthEquity in the third quarter valued at $112,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HealthEquity

In other news, Director Stuart B. Parker sold 25,000 shares of HealthEquity stock in a transaction that occurred on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. The trade was a 56.74 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $101.56, for a total value of $837,870.00. Following the transaction, the director now owns 66,469 shares of the company’s stock, valued at $6,750,591.64. This represents a 11.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by insiders.

HealthEquity Trading Up 0.3 %

NASDAQ HQY opened at $112.50 on Wednesday. The firm has a market cap of $9.75 billion, a P/E ratio of 103.21, a P/E/G ratio of 1.61 and a beta of 0.55. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The stock’s 50-day moving average is $101.40 and its 200-day moving average is $90.20. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $113.61.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Monday, December 9th. The company reported $0.59 EPS for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same period last year, the business posted $0.40 EPS. Sell-side analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

HQY has been the topic of several research analyst reports. BTIG Research increased their target price on HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a report on Thursday, November 14th. Bank of America increased their target price on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a report on Wednesday, November 13th. Barrington Research increased their target price on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a report on Monday, December 2nd. Mizuho initiated coverage on HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target on the stock. Finally, Royal Bank of Canada upped their price target on HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $110.71.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.